Loading...
Pomalidomide and dexamethasone in myelomatous pleural effusion
Myelomatous pleural effusion (MPE) is an uncommon clinical entity and occurs in less than 1% of all patients with multiple myeloma. MPE indicates a progression of disease, therefore is associated with a poor prognosis and estimated median survival of <3 months. Treatment of MPE is challenging, an...
Na minha lista:
| Udgivet i: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733099/ https://ncbi.nlm.nih.gov/pubmed/33303498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235899 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|